2016
DOI: 10.1155/2016/3607125
|View full text |Cite
|
Sign up to set email alerts
|

Multidrug-ResistantBacteroides fragilisBacteremia in a US Resident: An Emerging Challenge

Abstract: We describe a case of Bacteroides fragilis bacteremia associated with paraspinal and psoas abscesses in the United States. Resistance to b-lactam/b-lactamase inhibitors, carbapenems, and metronidazole was encountered despite having a recent travel history to India as the only possible risk factor for multidrug resistance. Microbiological cure was achieved with linezolid, moxifloxacin, and cefoxitin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 11 publications
1
10
0
Order By: Relevance
“…Of the anaerobes, only one B. fragilis isolates showed low resistant to both imipenem and metronidazole 1(0.61%), while 3(1.83%) showed resistance to piperacillin/tazobactam. This outcome is in sharp contrast to previous study [52] but is in consistent with the observation made by Boyanova et al [53] in a study [2,9] and metronidazole [2].…”
Section: Discussionsupporting
confidence: 89%
“…Of the anaerobes, only one B. fragilis isolates showed low resistant to both imipenem and metronidazole 1(0.61%), while 3(1.83%) showed resistance to piperacillin/tazobactam. This outcome is in sharp contrast to previous study [52] but is in consistent with the observation made by Boyanova et al [53] in a study [2,9] and metronidazole [2].…”
Section: Discussionsupporting
confidence: 89%
“…However, antibiotics, even used for short periods may raise the issue of both toxicity and the emergence of bacterial antibiotic resistance. The number of reports of multidrug-resistant B. fragilis strains has increased in the past decade [53,54,55]. In particular, at NYU Langone Medical Center, resistance rates for 361 Bacteroides isolates were evaluated over a 5-year time period which demonstrated overall resistance rates of 5% (17/361) to metronidazole, 4% (13/361) to carbapenems, and 0.3% (1/361) to both carbapenems and metronidazole [56].…”
Section: Discussionmentioning
confidence: 99%
“…Additional virulence determinants of this species include the presence of various fimbriae and adhesions, which help the bacteria to adhere to matrix proteins of the host [ 50 ]. The most significant role of B. fragilis as an infectious agent is thought to be in anaerobic bacteraemia, where the associated mortality is estimated to be around 19% (60% if left untreated) [ 84 , 85 ].…”
Section: Examples Of Clinically Relevant Anaerobic Bacteriamentioning
confidence: 99%
“…But if we observe the data from the (inter)national surveillance reports from Europe ( Table 6 ) [ 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 ] and the United States ( Table 7 ) [ 95 , 135 , 144 , 145 , 146 , 147 ], the same trends can be discovered: steadily growing resistance to all classes of antimicrobial agents, with some of them rendered completely useless. Several publications report the emergence of multidrug resistant anaerobic Gram-negative bacteria (especially within the B. fragilis group isolates), harbouring multiple resistance genes or with a combination of intrinsic and acquired resistance mechanisms [ 80 , 85 , 147 , 148 , 149 , 150 , 151 ]. In these cases, the bacteria were usually termed multidrug resistant if they were resistant to 3–4 antibiotic classes besides metronidazole (due to nim nitroimidazole resistance genes) and the carbapenems (a metallo-β-lactamase encoded by cfiA / ccrA genes) [ 79 ].…”
Section: Antibiotic Resistance In Anaerobic Bacteria: the Importanmentioning
confidence: 99%